RedHill Biopharma Ltd. (Nasdaq: RDHL) announced a research collaboration with Stanford University School of Medicine (“Stanford”) for the evaluation of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE